Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.
about
EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesisNotch signaling in pediatric soft tissue sarcomasSMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma.EZH2, a unique marker of malignancy in effusion cytology.Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma.EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approachesPoorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitroEZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD.Alveolar rhabdomyosarcoma: morphoproteomics and personalized tumor graft testing further define the biology of PAX3-FKHR(FOXO1) subtype and provide targeted therapeutic options.Epigenetic and genetic changes in soft tissue sarcomas: a review.Polycomb Repressor Complex 2 in Genomic Instability and CancerEwing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease.Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
P2860
Q34199631-685DA03A-9062-438E-931C-819F8388557FQ34480012-8D4954FB-9DFA-4A87-8267-F7897497B143Q34486393-6FA5FDC4-2C96-4BBA-B80F-98A31AB0A3C3Q34699488-7195ED17-97D3-4827-B2E1-F01DAF468431Q35942323-CA1B1754-A48A-4C1E-AFEC-EC1C12105128Q35949625-0F3E1394-705E-4DAD-AF2F-507815AB8AA0Q36388149-560EEB72-E3A3-4431-946C-7FF4E9FC9A6EQ36850467-07CB5921-396A-44E1-A85F-2C74B7547A26Q37420964-0BA130BD-612F-4C93-87E0-E6739D9B7E87Q37564708-D1B25373-7B09-4D21-B5CD-1D724D236CBAQ38964936-37ECEF73-31AB-4BD4-BFDC-FD4579EE46CCQ41573279-3E77BB8E-E255-494E-BFF1-C18ECB573A2AQ42006104-5AED1BE5-B6D4-418A-8ADA-4DDDD17FC5B4Q46116571-DC182E2B-1C4A-4E28-8512-DC38F69A7E8F
P2860
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.
@ast
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.
@en
type
label
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.
@ast
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.
@en
prefLabel
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.
@ast
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.
@en
P2860
P50
P921
P356
P1433
P1476
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.
@en
P2093
Roberta Ciarapica
P2860
P2888
P356
10.1186/1741-7015-9-63
P407
P5008
P577
2011-05-25T00:00:00Z
P5875
P6179
1042505345